4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001104659-16-124832
Options or other derivatives
- Chief Executive Officer acquired 524,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TABUTEAU HERRIOT Chief Executive Officer | 2016-05-27 | Grant or award · Employee Stock Option (Right to Buy) | +524,000 | 524,000 | D | ||
Loading xslF345X03/a4.xml…